Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Breast Care (Basel, Switzerland)|January 14, 2014
Is symptom-oriented follow-up still up to date?Christoph Mundhenke, Volker MoebusCancer Investigation|March 17, 2007
The FACE trial: letrozole or anastrozole as initial adjuvant therapy?Walter Jonat, Christoph MundhenkeBreast Care (Basel, Switzerland)|March 5, 2011
Adjuvant Consensus: A Breast Cancer Patient Web ToolWalter Jonat, Christoph Mundhenke, Manfred KaufmannBreast Care (Basel, Switzerland)|September 30, 2010
Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast CancerChristoph Mundhenke, Alexander Strauss, Christian SchemBreast Care (Basel, Switzerland)|September 9, 2010
Adjuvant Endocrine Therapy in Early Postmenopausal Breast CancerChristoph Mundhenke, Christian Schem, Walter JonatThe American Journal of Pathology|January 12, 2002
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomasChristoph Mundhenke, Kristy Meyer, Sally Drew, et al.Journal of Cancer Research and Therapeutics|September 2, 2017
Physical activity influences the immune system of breast cancer patientsThorsten Schmidt, Marion van Mackelenbergh, Daniela Wesch, et al.Archives of Gynecology and Obstetrics|October 11, 2017
CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohortFrederik Stuebs, Simone Heidemann, Almuth Caliebe, et al.Clinical Breast Cancer|November 12, 2002
Expression and regulation of tumor suppressor gene maspin in breast cancerNicolai Maass, Koichi Nagasaki, Martin Ziebart, et al.Matrix Biology : Journal of the International Society for Matrix Biology|June 5, 2003
Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cellsBrandon J Burbach, Andreas Friedl, Christoph Mundhenke, et al.Pageof 9